Mental Retardation, X-Linked Nonsyndromic
|
0.300 |
Biomarker
|
disease |
CLINGEN |
FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.
|
11889465 |
2002 |
Inflammation
|
0.200 |
Biomarker
|
phenotype |
RGD |
Up-regulation of fatty acid metabolizing-enzymes mRNA in rat spinal cord during persistent peripheral local inflammation.
|
14622223 |
2003 |
Intellectual Disability
|
0.160 |
Biomarker
|
group |
BEFREE |
As Drosophila Acsl and human ACSL4 are functionally conserved, our findings provide novel insights into a critical and previously unappreciated role of Acsl in neurogenesis and the pathogenesis of ACSL4-related ID.
|
30594466 |
2019 |
Intellectual Disability
|
0.160 |
GeneticVariation
|
group |
BEFREE |
Xq22.3-q23 deletion including ACSL4 in a patient with intellectual disability.
|
23520119 |
2013 |
Intellectual Disability
|
0.160 |
GeneticVariation
|
group |
BEFREE |
We also compared the clinical features of the family with three previously reported families with the ACSL4 gene deletion and found that ID with absent or severely delayed speech, midface hypoplasia, and facial hypotonia are consistent features observed in the absence of ACSL4 gene.
|
20186809 |
2010 |
Intellectual Disability
|
0.160 |
GeneticVariation
|
group |
BEFREE |
FACL4 gene mutations in three Italian MR pedigrees have been reported as causing non-specific mental retardation.
|
18614287 |
2008 |
Intellectual Disability
|
0.160 |
Biomarker
|
group |
BEFREE |
FACL4 is the first gene shown to be involved in nonspecific mental retardation and fatty-acid metabolism.
|
11889465 |
2002 |
Intellectual Disability
|
0.160 |
Biomarker
|
group |
BEFREE |
FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation.
|
9480748 |
1998 |
Intellectual Disability
|
0.160 |
Biomarker
|
group |
HPO |
|
|
|
Global developmental delay
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies.
|
16276108 |
2006 |
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Drooling
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Patent ductus arteriosus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Elliptocytosis, Hereditary
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Facial paralysis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Flatfoot
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Meckel Diverticulum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Moderate intellectual disability
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Obesity
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Proteinuria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Pyloric Stenosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Babinski Reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|